1,4-Naphthoquinones potently inhibiting P2X7 receptor activity

Eur J Med Chem. 2018 Jan 1:143:1361-1372. doi: 10.1016/j.ejmech.2017.10.033. Epub 2017 Oct 23.

Abstract

P2X7 receptor (P2X7R) is an ATP-gated ion-channel with potential therapeutic applications. In this study, we prepared and searched a series of 1,4-naphthoquinones derivatives to evaluate their antagonistic effect on both human and murine P2X7 receptors. We explored the structure-activity relationship and binding mode of the most active compounds using a molecular modeling approach. Biological analysis of this series (eight analogues and two compounds) revealed significant in vitro inhibition against both human and murine P2X7R. Further characterization revealed that AN-03 and AN-04 had greater potency than BBG and A740003 in inhibiting dye uptake, IL-1β release, and carrageenan-induced paw edema in vivo. Moreover, we used electrophysiology and molecular docking analysis for characterizing AN-03 and AN-04 action mechanism. These results suggest 1,4-napthoquinones, mainly AN-04, as potential leads to design new P2X7R blockers and anti-inflammatory drugs.

Keywords: Dye uptake; IL-1β release; Molecular docking; Naphthoquinones; P2X7 receptor; Paw edema.

MeSH terms

  • Animals
  • Drug Design
  • HEK293 Cells
  • Humans
  • Mice
  • Molecular Docking Simulation
  • Naphthoquinones / chemistry
  • Naphthoquinones / metabolism
  • Naphthoquinones / pharmacology*
  • Protein Conformation
  • Purinergic P2X Receptor Antagonists / chemistry
  • Purinergic P2X Receptor Antagonists / metabolism
  • Purinergic P2X Receptor Antagonists / pharmacology*
  • Receptors, Purinergic P2X7 / chemistry
  • Receptors, Purinergic P2X7 / metabolism*
  • Structure-Activity Relationship

Substances

  • Naphthoquinones
  • Purinergic P2X Receptor Antagonists
  • Receptors, Purinergic P2X7
  • 1,4-naphthoquinone